BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 6.02.2012

Exceptions or Alternatives to Labeling Requirements for Products Held by the Strategic National Stockpile

The Food and Drug Administration (FDA) is adopting as a final rule, without change, the interim final rule that issued regulations permitting FDA Center Directors to grant exceptions or alternatives to certain regulatory labeling requirements applicable to human drugs, biological products, or medical devices that are or will be included in the Strategic National Stockpile (SNS). FDA is taking this action to complete the rulemaking initiated with the interim final rule.

Source: Federal Register — Food and Drug AdministrationOpen original release →